Location:
International Food Policy Research Institute
2033 K Street, NW, Washington, DC
Fourth Floor Conference Facility
Thursday, November 15, 2001
3:30 - 5:00 p.m.

To date, 98 percent of all benefits from GMOs have come from the diffusion of two genetic events in four commercial crops in three countries. How can the research and regulatory investments needed to deliver the benefits of biotechnology to developing countries be supported? A major reason that the US dominates the science and business of biotechnology is the huge size and smooth functioning of its seed markets. Seed delivery becomes complicated when commercial markets are small or non-existent as they are for many pureline crops in the US, and for nearly all crops in small countries. This seminar will review evidence on the current use of GMOs and the generation of improved plant varieties. It will then discuss models that might allow developing countries access to the benefits of biotechnology.

Kindly RSVP to 202-862-8107 or Email: S.Hill-Lee@cgiar.org.